Overall, our data suggest that there is an ongoing molecular phenotype in Bcl11a-associated ID that is not restricted to early development and involves multiple post-natal molecular pathways underlying cognitive impairment and behavioral defects. The gene discussed is BCL11A; the disease is Cognitive impairment.